These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4973842)

  • 21. Impaired renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos T; Capitán MC; Gil AA
    Adv Exp Med Biol; 1989; 253A():269-76. PubMed ID: 2624202
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental studies of fructose overloading in normal subjects and in patients with gout].
    Bianco G; Di Paolo N; Lunghetti R; Bravi A
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):969-84. PubMed ID: 5760343
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental study on certain methods of decreasing the urinary excretion of uric acid.
    Sorrentino F
    Urol Int; 1970; 25(5):444-56. PubMed ID: 5525133
    [No Abstract]   [Full Text] [Related]  

  • 24. Allopurinol and thiopurinol: effect in vivo on urinary oxypurine excretion and rate of synthesis of their ribonucleotides in different enzymatic deficiencies.
    Auscher C; Mercier N; Pasquier C; Delbarre F
    Adv Exp Med Biol; 1974; 41():657-62. PubMed ID: 4832592
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of daily single doses of 300 mg allopurinol on serum uric acid concentration and urate excretion in gouty patients (author's transl)].
    Matzkies F; Berg G
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2464-5. PubMed ID: 4448143
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of xanthine oxidase inhibitor, 4-hydroxypyrazolo-(3, 4-d)-pyrimidine (zyloric) on the nucleic acid metabolism and its pharmacological actions. 1].
    Isa M; Hayashi G; Kowa Y
    Nihon Yakurigaku Zasshi; 1968 Mar; 64(2):108-22. PubMed ID: 5749287
    [No Abstract]   [Full Text] [Related]  

  • 28. Xanthinuria with myopathy (with some observations on the renal handling of oxypurines in the disease).
    Chalmers RA; Johnson M; Pallis C; Watts RW
    Q J Med; 1969 Oct; 38(152):493-512. PubMed ID: 5355540
    [No Abstract]   [Full Text] [Related]  

  • 29. Basic sciences in medicine: the example of gout.
    Stetten D
    N Engl J Med; 1968 Jun; 278(24):1333-6. PubMed ID: 5648600
    [No Abstract]   [Full Text] [Related]  

  • 30. Depletion of erythrocyte phosphoribosylpyrophosphate in man.
    Fox IH; Wyngaarden JB; Kelley WN
    N Engl J Med; 1970 Nov; 283(22):1177-82. PubMed ID: 4319625
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 32. [The action of ethanol in gout and on the metabolism of uric acid].
    Delbarre F; Auscher C; Brouilhet H; de Géry A
    Sem Hop; 1967 Feb; 43(10):659-64. PubMed ID: 4292985
    [No Abstract]   [Full Text] [Related]  

  • 33. [The influence of allopurinol on purine- and pyrimidinesynthesis (author's transl)].
    Gröbner W; Zöllner N
    Klin Wochenschr; 1978 Mar; 53(16):255-60. PubMed ID: 682520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function in gout. 3. Estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid).
    Gutman AB; Yü TF; Berger L
    Am J Med; 1969 Oct; 47(4):575-92. PubMed ID: 4898522
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular variation in relation to purine metabolism.
    Watts RW
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():48-63. PubMed ID: 4620886
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic effects of allopurinol and allo-xanthine.
    Rundles RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):615-20. PubMed ID: 5226510
    [No Abstract]   [Full Text] [Related]  

  • 37. Allopurinol in the therapy of neoplasia and blood diseases. Metabolic aspects.
    Watts RW
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):657-9. PubMed ID: 5226512
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary excretion of purines, pyrimidines and pyrazolopyrimidines in patients treated with allopurinol or oxipurinol.
    Simmonds HA
    Clin Chim Acta; 1969 Feb; 23(2):353-64. PubMed ID: 5764912
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathophysiology of purine metabolism in man.
    Kelley WN
    Enzyme; 1974; 18(3):161-75. PubMed ID: 4841658
    [No Abstract]   [Full Text] [Related]  

  • 40. [Relationship between the elevation of liver xanthine-oxidase, hyperuricemia and uricuria in gout].
    Ciccoli L; Riario-Sforza G; Marinello E; Marcolongo R; Carcassi A
    Reumatismo; 1969; 21(5):277-8. PubMed ID: 5404977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.